7.7
One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model
Extravascular administration, such as oral or intramuscular routes, is a non-invasive drug delivery method, often preferred for ease and patient compl…
Extravascular drug administration occurs via oral, intramuscular, or rectal routes.
It relies on absorption for the drug's therapeutic activity.
Here, the rate of absorption may be of two types: zero-order and first-order.
In zero-order absorption, the absorption rate remains constant over time independent of the amount remaining to be absorbed, unlike first-order absorption.
Now, the given equation expresses the rate of change in the amount of drug in the body post-administration.
For drugs following one-compartment kinetics, the plasma drug concentration-time profile is defined by absorption, post-absorption, and elimination phases.
During the absorption phase, the absorption rate exceeds the elimination rate. At peak plasma concentration, the rate of absorption equals its elimination rate.
During the post-absorption phase, the elimination rate exceeds the absorption rate.
Upon complete drug absorption, its rate becomes zero, defining the elimination phase in the plasma drug concentration-time curve.
View the full transcript and gain access to JoVE Core videos
Q1: What is zero-order absorption in pharmacokinetics?
Zero-order absorption is a constant-rate drug absorption process where the absorption rate remains steady over time, independent of the amount of drug remaining to be absorbed. This differs from first-order absorption, where the rate declines as drug amount decreases. Zero-order kinetics commonly applies to controlled-release systems like sustained-release tablets or transdermal patches, where absorption continues steadily until the drug at the absorption site is depleted.
Q2: How do absorption and elimination rates interact during the plasma concentration-time profile?
During the absorption phase, the absorption rate exceeds the elimination rate, causing plasma concentration to rise. At peak plasma concentration, absorption and elimination rates are equal. During the post-absorption phase, elimination rate exceeds absorption rate, causing concentration to decline. Once drug absorption completes, the elimination phase begins where absorption rate becomes zero and only elimination continues.
Q3: Why is extravascular drug administration preferred over intravenous routes?
Extravascular administration via oral, intramuscular, or rectal routes is non-invasive and often preferred for ease of use and improved patient compliance. These routes rely on absorption to deliver the drug's therapeutic activity. However, absorption rate—whether zero-order or first-order—becomes a critical factor determining how quickly and effectively the drug enters the bloodstream from the administration site.
Q4: What pharmacokinetic parameters are estimated in zero-order absorption models?
Key pharmacokinetic parameters estimated include the elimination rate constant (k), absorption rate constant (ka), maximum plasma concentration (Cmax), and time to reach maximum concentration (tmax). These parameters provide critical insights into drug behavior and effectiveness. Mathematical equations governing the one-compartment open model determine how absorption and elimination rates balance to produce the observed plasma concentration-time profile.
Q5: How does zero-order absorption compare to constant-rate intravenous infusion?
Zero-order absorption maintains a steady absorption rate similar to constant-rate intravenous infusion, where drug enters the body at a constant rate. The mathematical equations and principles governing plasma concentration-time profiles in constant-rate infusion also apply to zero-order absorption. Both processes result in linear drug input until the source is depleted, distinguishing them from first-order processes where input rate declines over time.
Q6: What routes of administration are considered extravascular?
Extravascular administration includes oral, intramuscular, and rectal routes. These non-invasive delivery methods rely on absorption for the drug to enter the bloodstream and exert therapeutic activity. The rate of absorption—either zero-order or first-order—determines how quickly the drug becomes available systemically, making absorption kinetics a fundamental consideration in pharmacokinetic modeling for these routes.
Q7: What types of drug delivery systems exhibit zero-order absorption kinetics?
Controlled-release systems such as sustained-release tablets and transdermal patches typically exhibit zero-order absorption kinetics. These formulations are designed to deliver drug at a constant rate over an extended period. Absorption continues steadily until the drug at the absorption site, such as the gastrointestinal tract, is completely depleted, providing predictable and consistent plasma concentration profiles.